Document is current
Any future updates will be listed below
-
Authors
Carpi, Matteo https://orcid.org/0000-0001-6933-5675
Mercuri, Nicola Biagio https://orcid.org/0000-0001-6700-7491
Liguori, Claudio https://orcid.org/0000-0003-2845-1332
-
Funding
Funding for this research was provided by:
Università degli Studi di Roma Tor Vergata
- License Information
-
More Information
Article History
Accepted: 9 September 2024
First Online: 4 October 2024
Declarations
:
: Open access funding provided by Università degli Studi di Roma Tor Vergata within the CRUI-CARE Agreement.
: Claudio Liguori has received honoraria from Idorsia, EISAI, and MSD for research support or advisory board participation. Claudio Liguori has participated as investigator in the clinical trials by Takeda. Matteo Carpi and Nicola Biagio Mercuri have no relevant financial or non-financial interest to disclose.
: An ethics statement is not applicable as this study is based exclusively on published literature and publicly available information on registered clinical trials.
: Not applicable.
: Not applicable.
: The data supporting the findings of this study are available within the article. The corresponding author can be contacted for further inquiries.
: Not applicable.
: All authors contributed to the conception and design of the study. Matteo Carpi and Claudio Liguori performed the literature search and review. Nicola Biagio Mercuri provided critical supervision. The first draft of the manuscript was written by Matteo Carpi and Claudio Liguori, and all authors commented on earlier versions of the manuscript. All authors read and approved the final version of the manuscript and agreed to be accountable for the work.
